Immune System Disorder clinical trials
9 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- Thrombosis and Inflammation in Vessels Initiative (TIVI)
- Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
- Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
- Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
- Biologics And Clinical Immunology Cohort at Sinai
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
- Evaluating the Effects of a Synbiotic Versus Probiotic or Placebo on Gut Microbiota and Cardiometabolic Health: A Randomized Double-Blind Placebo Controlled Trial
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Immune System Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.